171 related articles for article (PubMed ID: 8109914)
1. Antimicrobial activity of rabbit CAP18-derived peptides.
Larrick JW; Hirata M; Shimomoura Y; Yoshida M; Zheng H; Zhong J; Wright SC
Antimicrob Agents Chemother; 1993 Dec; 37(12):2534-9. PubMed ID: 8109914
[TBL] [Abstract][Full Text] [Related]
2. Rabbit CAP18 derived peptides inhibit gram negative and gram positive bacteria.
Larrick JW; Hirata M; Shimomoura Y; Yoshida M; Zheng H; Zhong J; Wright SC
Prog Clin Biol Res; 1994; 388():125-35. PubMed ID: 7831354
[TBL] [Abstract][Full Text] [Related]
3. Structure and functions of endotoxin-binding peptides derived from CAP18.
Hirata M; Zhong J; Wright SC; Larrick JW
Prog Clin Biol Res; 1995; 392():317-26. PubMed ID: 8524937
[TBL] [Abstract][Full Text] [Related]
4. Anti-microbial activity of human CAP18 peptides.
Larrick JW; Hirata M; Zhong J; Wright SC
Immunotechnology; 1995 May; 1(1):65-72. PubMed ID: 9373334
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.
Madanchi H; Ebrahimi Kiasari R; Seyed Mousavi SJ; Johari B; Shabani AA; Sardari S
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1582-1593. PubMed ID: 32445120
[TBL] [Abstract][Full Text] [Related]
7. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.
Larrick JW; Hirata M; Balint RF; Lee J; Zhong J; Wright SC
Infect Immun; 1995 Apr; 63(4):1291-7. PubMed ID: 7890387
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial action of rabbit leukocyte CAP18(106-137).
Mason DJ; Dybowski R; Larrick JW; Gant VA
Antimicrob Agents Chemother; 1997 Mar; 41(3):624-9. PubMed ID: 9056004
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.
Sawa T; Kurahashi K; Ohara M; Gropper MA; Doshi V; Larrick JW; Wiener-Kronish JP
Antimicrob Agents Chemother; 1998 Dec; 42(12):3269-75. PubMed ID: 9835525
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity.
Hirata M; Shimomura Y; Yoshida M; Morgan JG; Palings I; Wilson D; Yen MH; Wright SC; Larrick JW
Infect Immun; 1994 Apr; 62(4):1421-6. PubMed ID: 8132348
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide.
Swierzko AS; Kirikae T; Kirikae F; Hirata M; Cedzynski M; Ziolkowski A; Hirai Y; Kusumoto S; Yokochi T; Nakano M
J Med Microbiol; 2000 Feb; 49(2):127-138. PubMed ID: 10670563
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.
Kirikae T; Hirata M; Yamasu H; Kirikae F; Tamura H; Kayama F; Nakatsuka K; Yokochi T; Nakano M
Infect Immun; 1998 May; 66(5):1861-8. PubMed ID: 9573062
[TBL] [Abstract][Full Text] [Related]
14. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity.
Larrick JW; Hirata M; Zheng H; Zhong J; Bolin D; Cavaillon JM; Warren HS; Wright SC
J Immunol; 1994 Jan; 152(1):231-40. PubMed ID: 8254193
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids.
Gutsmann T; Fix M; Larrick JW; Wiese A
J Membr Biol; 2000 Aug; 176(3):223-36. PubMed ID: 10931974
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.
Tossi A; Scocchi M; Skerlavaj B; Gennaro R
FEBS Lett; 1994 Feb; 339(1-2):108-12. PubMed ID: 8313956
[TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide of human apoprotein E with antibacterial activity.
Azuma M; Kojimab T; Yokoyama I; Tajiri H; Yoshikawa K; Saga S; Del Carpio CA
Peptides; 2000 Mar; 21(3):327-30. PubMed ID: 10793212
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of mammalian cathelicidin-derived peptides.
Travis SM; Anderson NN; Forsyth WR; Espiritu C; Conway BD; Greenberg EP; McCray PB; Lehrer RI; Welsh MJ; Tack BF
Infect Immun; 2000 May; 68(5):2748-55. PubMed ID: 10768969
[TBL] [Abstract][Full Text] [Related]
19. Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein.
Larrick JW; Morgan JG; Palings I; Hirata M; Yen MH
Biochem Biophys Res Commun; 1991 Aug; 179(1):170-5. PubMed ID: 1883348
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
